Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068119 · ClinicalTrials.gov registry record · Phase 4
Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)
A Phase 4 study, sponsored by Piedmont Healthcare.
- Terminated
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
NCT01068119: Clinical Trial Phase 4 study, sponsored by Piedmont Healthcare.
NCT01068119 is a Phase 4 study that was terminated before completion, run by Piedmont Healthcare. The registered enrollment target is 57 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01068119, a Phase 4 study, was terminated before completion, sponsored by Piedmont Healthcare.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
Study Summary
Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.
Interventions
- PROCEDURE Same-day discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Why NCT01068119 stopped before completion
NCT01068119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Same-day discharge is the first listed.
NCT01068119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01068119 about?
NCT01068119 is a clinical study titled "Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)". Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.
What is the current status of trial NCT01068119?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2010-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01068119?
The interventions under investigation include: Same-day discharge (PROCEDURE).
Who is sponsoring clinical trial NCT01068119?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01068119's enrollment target sits among peer trials
57 1209th of 2000 higher than 788 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia